Danimer Scientific, Inc.
DNMR · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $4 | $7 | $32 | $79 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $5 | $7 | $32 | $79 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -12.3% | -9.4% | 24.1% | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | -57.7% | -14.9% | 1.5% | 24.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -205.9% | -194.5% | -149.3% | -3.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -333% | -337.8% | -102.3% | -18.7% |
| EPS Diluted | -1.52 | -1.78 | -0.65 | -0.1 |
| % Growth | 14.6% | -173.8% | -550% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |